This analysis provides critical insight into the role of HIF-1α in the hypoxic amplification of BMP signaling and in the episodic induction of HO in FOP and further identifies HIF-1α as a therapeutic target for FOP and perhaps nongenetic forms of HO [28]. This evidence concerns the gene HMOX1 and fibrodysplasia ossificans progressiva.